Spalinskas R

Family name	Spalinskas
Given name	Rapolas
Initials	R
ORCID	ORCID 0000-0002-1648-6426
Affiliations	Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Gene Technology, KTH Royal Institute of Technology, Solna, Sweden.

2 publications

PubMed DOI Crossref

Enhancer mutations modulate the severity of chemotherapy-induced myelosuppression.

Zhigulev A, Norberg Z, Cordier J, ..., Gréen H, Sahlén P

Life Sci. Alliance 7 (3) - [2024-03-00; online 2024-01-16]

Bioinformatics Support for Computational Resources [Service] NGI Short read [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

PubMed DOI Crossref

Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients.

Björn N, Badam TVS, Spalinskas R, ..., Gustafsson M, Gréen H

npj Syst Biol Appl 6 (1) 25 [2020-08-24; online 2020-08-24]

Bioinformatics Support for Computational Resources [Service] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

SciLifeLab Data Centre

Publications 9.5.1